title: Integrated treatment for lower-limb stage II thromboangiitis obliterans by interventional therapy and oral administration of Chinese medicine: a randomized controlled clinical trial.
abstract: METHODS
  Ninety lower-limb stage II or worse TAO patients were randomly divided into three groups: group A (30 cases) treated by intervention and oral administration of Chinese medicine; group B (30 cases) treated by intervention alone; and group C (30 cases) treated only with oral administration of Chinese medicine. Therapeutic effects were observed, including the cure rate; the recurrence rate after one month, three months, six months, nine months, and one year; the ankle brachial indexes; the incidence of complications; and the level of C-reactive protein and erythrocyte sedimentation rate.
  
  
  RESULTS
  Group A had significantly better clinically curative effects, related indexes, and outcomes during the long-term follow-up survey, than that of groups B and C.
  
  
  CONCLUSIONS
  Integrated treatment is more effective for treating lower-limb stage II or worse TAO.
  
  
  OBJECTIVE
  To observe if integrated treatment is better than other therapies for lower-limb stage II thromboangiitis obliterans (TAO).
authors.forename: Yaowen
authors.initials: Y
authors.lastname: Chang
authors.forename: Fenqiang
authors.initials: F
authors.lastname: Li
authors.forename: Wenhui
authors.initials: W
authors.lastname: Wang
authors.forename: Laichang
authors.initials: L
authors.lastname: Song
authors.forename: Li
authors.initials: L
authors.lastname: Li
authors.forename: Zhengfei
authors.initials: Z
authors.lastname: Li
authors.forename: Dongjun
authors.initials: D
authors.lastname: Su
authors.forename: Zhaoliang
authors.initials: Z
authors.lastname: Fu
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001241:Aspirin / Q000008:administration & dosage*; D002097:C-Reactive Protein / Q000378:metabolism; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013919:Thromboangiitis Obliterans / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D004365:Drugs, Chinese Herbal; D002097:C-Reactive Protein; D001241:Aspirin